AnPac Bio-Medical Science Co., Ltd. (ANPC) |
| 4.3 -0.14 (-3.15%) 05-19 15:59 |
| Open: | 4.57 |
| High: | 4.63 |
| Low: | 4.25 |
| Volume: | 35,704 |
| Market Cap: | 27(M) |
| PE Ratio: | -0.38 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 22.94 |
| Resistance 1: | 19.64 |
| Pivot price: | 18.20 |
| Support 1: | 18.06 |
| Support 2: | 17.09 |
| 52w High: | 11.99 |
| 52w Low: | 2.6 |
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.
Financials
| EPS | 0.700 |
| Book Value | 0.070 |
| PEG Ratio | 0.00 |
| Gross Profit | 22.042 |
| Profit Margin (%) | 0.56 |
| Operating Margin (%) | 1.52 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 14 Oct 2022
Why Otonomy Shares Dipped By Around 54%; Here Are 67 Biggest Movers From Yesterday By Benzinga - Investing.com UK
Fri, 25 Mar 2022
AnPac Bio-Medical Sciences Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing - Yahoo Finance
Mon, 13 Sep 2021
Idera Pharmaceuticals - IDRA - Stock Price & News - The Motley Fool
Sat, 12 Dec 2020
Anpac Bio-medical Science . Stock Price Forecast. Should You Buy ANPC? - StockInvest.us
Fri, 28 Aug 2020
Latest ANPC News - Fresh2 Group Ltd. Announces Nasdaq Ticker S... - Stock Titan
Thu, 30 Apr 2020
ANPC: A Blood Test for Cancer Diagnosis - Zacks Small Cap Research
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
